{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-018375","form_type":"8-K","ticker":"FZMD","cik":"0000319016","company_name":"Fuse Medical, Inc.","filed_at":"2023-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.781275+00:00","generated_at":"2026-06-13T17:22:54.284999+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Fuse Medical holds 2023 Annual Meeting; all director nominees elected and auditor ratified","bullets":["All four director nominees elected with >98% votes for: Bosita, Brooks, Yellin, Reeg.","Ratification of M&K CPAS as independent auditor for FY2023: 64,474,346 for, 47,224 against, 191 abstain.","Quorum of 64,521,761 shares present out of 73,895,794 eligible shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-018375","json":"https://secwatch.observer/filing/0001437749-23-018375.json","markdown":"https://secwatch.observer/filing/0001437749-23-018375.md","text":"https://secwatch.observer/filing/0001437749-23-018375.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/319016/000143774923018375/0001437749-23-018375-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/319016/000143774923018375/fzmd20230623_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T17:22:54.284999+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"945061acc52dd1a23814fab26d80149e5d5c8efc","claim":"Fuse Medical, Inc. shareholders approved Ratification of the Selection of M&K CPAS, PLLC at the 2023-06-23 meeting.","evidence_excerpt":"The selection of M&K to act as an independent registered public accounting firm for the Company for the fiscal year ending December 31, 2023 was ratified by a vote of (i) 64,474,346 in favor, (ii) 47,224 against, and (iii) 191 abstaining.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/319016/000143774923018375/0001437749-23-018375-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-23"}],"fact_type":"shareholder_vote"},{"claim_id":"a6a813973d5e2cff55d31331b4f05043ffba8c9f","claim":"Fuse Medical, Inc. shareholders approved Election of Board of Directors at the 2023-06-23 meeting.","evidence_excerpt":"The following persons were elected as directors of the Company for a one-year term expiring at the 2024 Annual Meeting of Stockholders with the following vote: Name Votes For Votes Against Votes Withheld Broker Non-Votes Renato V. Bosita, Jr., MD 63,087,944 61,351 2 1,372,464 Mark W. Brooks 63,132,848 16,447 2 1,372,464 Lawrence S. Yellin 63,091,848 57,447 2 1,372,464 Christopher C. Reeg 63,132,854 16,441 2 1,372,464","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/319016/000143774923018375/0001437749-23-018375-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-23"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}